Terhi Kärpänen

8.6k total citations · 4 hit papers
39 papers, 6.8k citations indexed

About

Terhi Kärpänen is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Terhi Kärpänen has authored 39 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 27 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Terhi Kärpänen's work include Lymphatic System and Diseases (31 papers), Angiogenesis and VEGF in Cancer (23 papers) and Sympathectomy and Hyperhidrosis Treatments (8 papers). Terhi Kärpänen is often cited by papers focused on Lymphatic System and Diseases (31 papers), Angiogenesis and VEGF in Cancer (23 papers) and Sympathectomy and Hyperhidrosis Treatments (8 papers). Terhi Kärpänen collaborates with scholars based in Finland, Japan and Netherlands. Terhi Kärpänen's co-authors include Kari Alitalo, Seppo Ylä‐Herttuala, Hajime Kubo, Taija Mäkinen, Michael Jeltsch, Yulong He, Tanja Veikkola, David G. Jackson, Lotta Jussila and Marc G. Achen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Terhi Kärpänen

38 papers receiving 6.6k citations

Hit Papers

Inhibition of lymphangiogenesis with resulting lymphedema... 2001 2026 2009 2017 2001 2001 2001 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
    2001 612 citations Taija Mäkinen, Lotta Jussila et al. Nature Medicine profile →
  2. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
    2001 531 citations Terhi Kärpänen, Mikala Egeblad et al. Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) profile →
  3. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
    2001 518 citations Tanja Veikkola, Lotta Jussila et al. profile →
  4. Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome
    2002 507 citations Yan Zhou, Michael McMaster et al. American Journal Of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terhi Kärpänen Finland 32 4.5k 4.0k 1.3k 1.1k 702 39 6.8k
Vladimir Joukov Finland 27 4.2k 0.9× 5.8k 1.4× 984 0.7× 728 0.6× 572 0.8× 34 7.9k
Katri Pajusola Finland 23 3.3k 0.7× 4.0k 1.0× 907 0.7× 729 0.6× 607 0.9× 30 5.5k
Michael Jeltsch Finland 40 7.2k 1.6× 8.1k 2.0× 2.2k 1.7× 1.7k 1.5× 1.3k 1.9× 73 12.3k
Joe Kowalski United States 23 1.8k 0.4× 5.8k 1.5× 881 0.7× 451 0.4× 777 1.1× 25 8.7k
Bronislaw Pytowski United States 37 3.6k 0.8× 3.5k 0.9× 1.1k 0.8× 923 0.8× 359 0.5× 61 6.5k
Marika J. Karkkainen Finland 29 4.9k 1.1× 4.2k 1.1× 1.5k 1.1× 1.3k 1.2× 786 1.1× 31 7.0k
Pamela F. Jones United Kingdom 22 1.6k 0.3× 7.2k 1.8× 869 0.7× 293 0.3× 612 0.9× 45 9.5k
Michelle Letarte Canada 54 1.6k 0.4× 5.0k 1.3× 1.4k 1.1× 542 0.5× 314 0.4× 173 12.3k
Mats Hellström Sweden 24 978 0.2× 4.6k 1.2× 1.0k 0.8× 303 0.3× 559 0.8× 42 7.2k
Guo‐Hua Fong United States 32 876 0.2× 4.0k 1.0× 594 0.4× 535 0.5× 509 0.7× 55 5.9k

Countries citing papers authored by Terhi Kärpänen

Since Specialization
Citations

This map shows the geographic impact of Terhi Kärpänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terhi Kärpänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terhi Kärpänen more than expected).

Fields of papers citing papers by Terhi Kärpänen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terhi Kärpänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terhi Kärpänen. The network helps show where Terhi Kärpänen may publish in the future.

Co-authorship network of co-authors of Terhi Kärpänen

This figure shows the co-authorship network connecting the top 25 collaborators of Terhi Kärpänen. A scholar is included among the top collaborators of Terhi Kärpänen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terhi Kärpänen. Terhi Kärpänen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jha, Sawan Kumar, Terhi Kärpänen, Veli‐Matti Leppänen, et al.. (2017). Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific Reports. 7(1). 4916–4916. 66 indexed citations
2.
Kärpänen, Terhi & Johanna Olweus. (2017). The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy. Frontiers in Immunology. 8. 1718–1718. 39 indexed citations
3.
Jeltsch, Michael, Sawan Kumar Jha, Denis Tvorogov, et al.. (2014). CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation. Circulation. 129(19). 1962–1971. 178 indexed citations
4.
Guen, Ludovic Le, Terhi Kärpänen, Dörte Schulte, et al.. (2014). Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis. Development. 141(6). 1239–1249. 135 indexed citations
5.
Kärpänen, Terhi & Stefan Schulte‐Merker. (2011). Zebrafish Provides a Novel Model for Lymphatic Vascular Research. Methods in cell biology. 105. 223–238. 15 indexed citations
6.
Pedrioli, Deena M. Leslie, Terhi Kärpänen, Giorgia Jurisic, et al.. (2010). miR-31 Functions as a Negative Regulator of Lymphatic Vascular Lineage-Specific Differentiation In Vitro and Vascular Development In Vivo. Molecular and Cellular Biology. 30(14). 3620–3634. 93 indexed citations
7.
8.
Kärpänen, Terhi, Maija Bry, Hanna M. Ollila, et al.. (2008). Overexpression of Vascular Endothelial Growth Factor-B in Mouse Heart Alters Cardiac Lipid Metabolism and Induces Myocardial Hypertrophy. Circulation Research. 103(9). 1018–1026. 119 indexed citations
9.
Kärpänen, Terhi & Kari Alitalo. (2007). Molecular Biology and Pathology of Lymphangiogenesis. Annual Review of Pathology Mechanisms of Disease. 0(0). 3056952826–3056952826. 5 indexed citations
10.
Kärpänen, Terhi, Maria Wirzenius, Taija Mäkinen, et al.. (2006). Lymphangiogenic Growth Factor Responsiveness Is Modulated by Postnatal Lymphatic Vessel Maturation. American Journal Of Pathology. 169(2). 708–718. 109 indexed citations
11.
Jeltsch, Michael, et al.. (2006). Vascular Endothelial Growth Factor (VEGF)/VEGF-C Mosaic Molecules Reveal Specificity Determinants and Feature Novel Receptor Binding Patterns. Journal of Biological Chemistry. 281(17). 12187–12195. 32 indexed citations
12.
Kärpänen, Terhi. (2006). Lymphatic vessels in health and disease: Role of the VEGF-C/VEGFR-3 pathway and the transcription factor FOXC2. Työväentutkimus Vuosikirja. 2 indexed citations
13.
Bhardwaj, Shalini, Terhi Kärpänen, Suvi Jauhiainen, et al.. (2005). Periadventitial angiopoietin-1 gene transfer induces angiogenesis in rabbit carotid arteries. Gene Therapy. 12(5). 388–394. 12 indexed citations
14.
Kärpänen, Terhi & Taija Mäkinen. (2005). Regulation of lymphangiogenesis—From cell fate determination to vessel remodeling. Experimental Cell Research. 312(5). 575–583. 35 indexed citations
15.
Zhou, Yan, Michael McMaster, Mary J. Janatpour, et al.. (2002). Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome. American Journal Of Pathology. 160(4). 1405–1423. 507 indexed citations breakdown →
16.
Kärpänen, Terhi, Mikala Egeblad, Marika J. Karkkainen, et al.. (2001). Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.. Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory). 61(5). 1786–90. 531 indexed citations breakdown →
17.
Heino, Tapio I., Terhi Kärpänen, Gudrun Wahlström, et al.. (2001). The Drosophila VEGF receptor homolog is expressed in hemocytes. Mechanisms of Development. 109(1). 69–77. 94 indexed citations
18.
Mäkinen, Taija, Lotta Jussila, Tanja Veikkola, et al.. (2001). Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nature Medicine. 7(2). 199–205. 612 indexed citations breakdown →
19.
Saaristo, Anne, Terhi Kärpänen, & Kari Alitalo. (2000). Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene. 19(53). 6122–6129. 224 indexed citations
20.
Stacker, Steven A., Kaye L. Stenvers, Carol Caesar, et al.. (1999). Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent Homodimers. Journal of Biological Chemistry. 274(45). 32127–32136. 269 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vladimir Joukov Breakdown of academic impact, for papers by Katri Pajusola Breakdown of academic impact, for papers by Michael Jeltsch Breakdown of academic impact, for papers by Joe Kowalski Breakdown of academic impact, for papers by Bronislaw Pytowski Breakdown of academic impact, for papers by Marika J. Karkkainen Breakdown of academic impact, for papers by Pamela F. Jones Breakdown of academic impact, for papers by Michelle Letarte Breakdown of academic impact, for papers by Mats Hellström Breakdown of academic impact, for papers by Guo‐Hua Fong
Rankless by CCL
2026